Enhancing Lung Cancer Screening Through Human-Centered Intervention

Lung Cancer Clinical Trial

— ELFE  

Official title:

Enhancing Lung Cancer Screening Through Human-Centered Intervention

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06351085
• Other study ID #: 1937769-1
• Status: Recruiting
• Phase: N/A
• Start date: November 10, 2022
• Est. completion date: April 14, 2025

Study information

• Verified date: April 2024
• Source: University of California, Davis
• Contact: Lucy Rios, M.P.H.
• Phone: 916-734-7722
• Email: lucrios[@]ucdavis.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to further understand the factors involved in increasing lung cancer screening.

Description:

The study aims to identify patient, primary care team and health system factors that facilitate participation in lung cancer screening. Additionally, conduct a two-arm randomized comparative effectiveness intervention study to increase lung cancer screening compared with a usual care control arm and further evaluate the differential impact of the intervention conditions compared to usual care.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2869
• Est. completion date: April 14, 2025
• Est. primary completion date: April 14, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 50 Years to 80 Years

Eligibility

Inclusion Criteria:

Interviews:

• UC Davis Health Systems (UCDHS) primary care providers and clinic staff who provide services to patients ages 50-80.

• Patients who are eligible for lung cancer screening.

Screening Intervention:

• Patients ages 50-80 who have a history of smoking per review of their electronic medical record and who receive care at the following UCDH ambulatory care clinics: Ellison Ambulatory Care Clinic; Elk Grove; Midtown.

Exclusion Criteria:

Interviews:

• Non-consenting patients and patients who do not speak English or Spanish

• Patients aged 49 and younger

• Non UCDHS primary care providers and clinic staff

Screening Intervention:

• UCDHS patients who have already received Lung Cancer Screening

• Patients with existing Cancer diagnosis

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

Intervention

Behavioral:
• Pre-Visit Planner
The study is comparing the implementation of a Pre-Visit Planner to go through the shared decision making process.
• Pre-Visit Planner + MyChart
The study is comparing the implementation of a Pre-Visit Planner to go through the shared decision making process as well as testing if watching educational videos about the Lung Cancer Screening (LCS) process prior to talking to an LVN will help with LCS uptake.

Locations

Country	Name	City	State
United States	University of California, Davis	Sacramento	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Lung Cancer Screening	The primary outcome is the proportion of patients aged 50-80 with a history of smoking who receive Lung Cancer Screening during the study period; this outcome will be measured in both intervention groups and the control group.	156 Weeks
Secondary	Completion of Interviews with Staff and Patients	Key informant interviews with UC Davis staff and patients to determine approach to intervention.	156 Weeks